AAAAAA

   
Results: 1-16 |
Results: 16
MALE BREAST-CANCER - A RETROSPECTIVE ANALYSIS OF PATIENTS TREATED IN TRIESTE, ITALY
Authors: SANDRI P VIDALI C MILAN V TRIVILLIN V MUSTACCHI G
Citation: P. Sandri et al., MALE BREAST-CANCER - A RETROSPECTIVE ANALYSIS OF PATIENTS TREATED IN TRIESTE, ITALY, European journal of cancer, 34, 1998, pp. 216-216
R2 - INDEX OF BIOLOGICAL AGGRESSIVE BREAST-CANCER
Authors: CHERUBINI M BAXA P SUSTERSICH M MUSTACCHI G
Citation: M. Cherubini et al., R2 - INDEX OF BIOLOGICAL AGGRESSIVE BREAST-CANCER, European journal of cancer, 34, 1998, pp. 503-503
EARLY PROPHYLAXIS WITH TROPISETRON P.O. FOR DELAYED CHEMOTHERAPY-INDUCED EMESIS - A PHASE-II OPEN STUDY
Authors: MUSTACCHI G CECCHERINI R MILANI S SLAUNIG S LEITA ML
Citation: G. Mustacchi et al., EARLY PROPHYLAXIS WITH TROPISETRON P.O. FOR DELAYED CHEMOTHERAPY-INDUCED EMESIS - A PHASE-II OPEN STUDY, Annals of oncology, 9, 1998, pp. 721-721
GASTROPROTECTION FOR ONCOLOGICAL PATIENTS - RATIONAL APPROACH, ROLE OF ANTISECRETORY AGENTS AND FUTURE OUTLOOK IN ONCOLOGY
Authors: MUSTACCHI G CECCHERINI R
Citation: G. Mustacchi et R. Ceccherini, GASTROPROTECTION FOR ONCOLOGICAL PATIENTS - RATIONAL APPROACH, ROLE OF ANTISECRETORY AGENTS AND FUTURE OUTLOOK IN ONCOLOGY, Tumori, 84(1), 1998, pp. 16-19
MODULATING EFFECT OF LONIDAMINE ON RESPONSE TO DOXORUBICIN IN METASTATIC BREAST-CANCER PATIENTS - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL
Authors: AMADORI D FRASSINETI GL DEMATTEIS A MUSTACCHI G SANTORO A CARIELLO S FERRARI M NASCIMBEN O NANNI O LOMBARDI A SCARPI E ZOLI W
Citation: D. Amadori et al., MODULATING EFFECT OF LONIDAMINE ON RESPONSE TO DOXORUBICIN IN METASTATIC BREAST-CANCER PATIENTS - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Breast cancer research and treatment, 49(3), 1998, pp. 209-217
A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING ONDANSETRON VERSUS ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED DELAYED EMESIS
Authors: GRIDELLI C IANNIELLO GP AMBROSINI G MUSTACCHI G PEDICINI T FARRIS A IACOBELLI S ROSSI G MORETTI G ANGELINI F DELENA M DICARLO A BONSIGNORI M SABBATINI R CATALANO G ROSSI A OLIVIERI A FINA P BIANCO AR
Citation: C. Gridelli et al., A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING ONDANSETRON VERSUS ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED DELAYED EMESIS, International journal of oncology, 10(2), 1997, pp. 395-400
CLINICAL EFFICACY AND ENDOCRINE ACTIVITY OF VOROZOLE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC PHASE-II STUDY
Authors: BOCCARDO F AMOROSO D IACOBELLI S IRTELLI L FARRIS A MUSTACCHI G MESITI M BREMA F PACINI P CORTESI E NARDINI P GUIDA G LANGENAEKEN C
Citation: F. Boccardo et al., CLINICAL EFFICACY AND ENDOCRINE ACTIVITY OF VOROZOLE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC PHASE-II STUDY, Annals of oncology, 8(8), 1997, pp. 745-750
DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/
Authors: BRUFMAN G COLAJORI E GHILEZAN N LASSUS M MARTONI A PEREVODCHIKOVA N TOSELLO C VIARO D ZIELINSKI C KRAINER M SALZER H SCHULLER J DITTRICH C SCHEITHAUER W ZAMAGNI C AMBROSINI G COLUCCI G GENTILINI P ZANIBONI A PACINI P BIANCO R MUSTACCHI G DAPRILE M DEMATTEIS A OLIVEIRA C JORDAAN J GUDGEON A VANZYL J RAKOWSKY E INBAR M RATH P COHEN Y SHANI A FRIED G HEGG R NETO AB BADER G BRAGA RF VITOC C PUERTO VML VALLE AE SALAZAR JD SANCHEZ JC VILLELA GM FOUNTZILAS G
Citation: G. Brufman et al., DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/, Annals of oncology, 8(2), 1997, pp. 155-162
LACK OF EFFECTIVENESS OF ADJUVANT ALTERNATING CHEMOTHERAPY IN NODE-POSITIVE, ESTROGEN-RECEPTOR-NEGATIVE PREMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC ITALIAN STUDY
Authors: BOCCARDO F RUBAGOTTI A AMOROSO D PERROTTA A SISMONDI P FARRIS A MESITI M GALLO L PACINI P VILLA E AGOSTARA B GENTA F DESANCTIS C SCOTTO T SPADARO P BUCCARAN G CAPPELLINI M BOLOGNESI A ALDRIGHETTI D TRAINA A SCHIEPPATI G SASSI M MUSTACCHI G BENETTI GP BANDUCCI S GATTI C ROLFO F IACOBELLI S IRTELLI L
Citation: F. Boccardo et al., LACK OF EFFECTIVENESS OF ADJUVANT ALTERNATING CHEMOTHERAPY IN NODE-POSITIVE, ESTROGEN-RECEPTOR-NEGATIVE PREMENOPAUSAL BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC ITALIAN STUDY, Cancer investigation, 15(6), 1997, pp. 505-512
EFFICACY OF THE SEQUENTIAL ADMINISTRATION OF G-CSF AND GM-CSF FOLLOWING CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER - RESULTS OF A RANDOMIZED STUDY
Authors: MUSTACCHI G CECCHERINI R MILANI S SANDRI P LEITA ML CARBONARA T
Citation: G. Mustacchi et al., EFFICACY OF THE SEQUENTIAL ADMINISTRATION OF G-CSF AND GM-CSF FOLLOWING CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER - RESULTS OF A RANDOMIZED STUDY, Tumori, 83(5), 1997, pp. 13-16
THE COMBINATION OF METOCLOPRAMIDE, METHYLPREDNISOLONE AND ONDANSETRONAGAINST ANTIBLASTIC-DELAYED EMESIS - A RANDOMIZED PHASE-II STUDY
Authors: MUSTACCHI G CECCHERINI R LEITA ML SANDRI P MILANI S CARBONARA T
Citation: G. Mustacchi et al., THE COMBINATION OF METOCLOPRAMIDE, METHYLPREDNISOLONE AND ONDANSETRONAGAINST ANTIBLASTIC-DELAYED EMESIS - A RANDOMIZED PHASE-II STUDY, Anticancer research, 17(2B), 1997, pp. 1345-1348
FACTORS THAT PREDICT RESPONSE AND DISEASE-FREE SURVIVAL IN CLINICALLYADVANCED FOLLICULAR LYMPHOMAS
Authors: GENUA A BISCOTTINI B CINIERI S TROTTINI M DERENZO A ROTOLI B TAFUTO S ABATE G MILANI S MUSTACCHI G AMBROSI L LEONI P MASTRIA A LORUSSO V VECCHI A SACCHI S PALMIERI F VOLPE E AZZOLINI C DAMMACCO F DICOSTANZO F CAPARROTTI G GRIGNANI F DEANGELIS V ALSHARJABY N LIBERATI AM
Citation: A. Genua et al., FACTORS THAT PREDICT RESPONSE AND DISEASE-FREE SURVIVAL IN CLINICALLYADVANCED FOLLICULAR LYMPHOMAS, Blood, 90(10), 1997, pp. 842-842
EXTRAGONADAL GERM-CELL TUMOR - A CLINICAL-STUDY
Authors: BASSETTO MA PASINI F FRANCESCHI T MUSTACCHI G CETTO GL
Citation: Ma. Bassetto et al., EXTRAGONADAL GERM-CELL TUMOR - A CLINICAL-STUDY, Anticancer research, 15(6B), 1995, pp. 2751-2754
LONIDAMINE IN MODULATION OF RESPONSE TO ADRIAMYCIN IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS
Authors: FRASSINETI GL NANNI O MILANDRI C FERRARI M DEMATTEIS A MUSTACCHI G CARIELLO S MASCIA V SANTORO A AMADORI D LOMBARDI A
Citation: Gl. Frassineti et al., LONIDAMINE IN MODULATION OF RESPONSE TO ADRIAMYCIN IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS, International journal of oncology, 4, 1994, pp. 741-746
TAMOXIFEN OR SURGERY PINS TAMOXIFEN AS PRIMARY-TREATMENT FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER - THE GRETA TRIAL
Authors: MUSTACCHI G MILANI S PLUCHINOTTA A DEMATTEIS A RUBAGOTTI A PERROTA A BOLOGNESI A BONI C CACIOPPO C CECCHERINI R FARRIS A GAMBROSIER P GARATTINI P MAIORINO L SANTORO A SCANNI A SCHIEPPATI G SISMONDI P TRAINA A TARQUINI A ZADRO A
Citation: G. Mustacchi et al., TAMOXIFEN OR SURGERY PINS TAMOXIFEN AS PRIMARY-TREATMENT FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER - THE GRETA TRIAL, Anticancer research, 14(5B), 1994, pp. 2197-2200
HIGH-DOSE FOLINIC ACID (FA) AND FLUOROURACIL (FU) PLUS OR MINUS THYMOSTIMULIN (TS) FOR TREATMENT OF METASTATIC COLORECTAL-CANCER - RESULTS OF A RANDOMIZED MULTICENTER CLINICAL-TRIAL
Authors: MUSTACCHI G PAVESI L MILANI S IAFFAIOLI V CARACO A COMELLA G CONTU A FARRIS A ATTADOPARINELLO G NARCISI M BREMA F BENI A BUMMA C
Citation: G. Mustacchi et al., HIGH-DOSE FOLINIC ACID (FA) AND FLUOROURACIL (FU) PLUS OR MINUS THYMOSTIMULIN (TS) FOR TREATMENT OF METASTATIC COLORECTAL-CANCER - RESULTS OF A RANDOMIZED MULTICENTER CLINICAL-TRIAL, Anticancer research, 14(2B), 1994, pp. 617-619
Risultati: 1-16 |